Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last $18.09 USD
Change Today -0.43 / -2.32%
Volume 319.8K
LMNX On Other Exchanges
As of 8:10 PM 02/5/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

12212 Technology Boulevard

Austin, TX 78727

United States

Phone: 512-219-8020

Fax: 512-219-5195

Luminex Corporation is engaged in the development, manufacture, and sale of proprietary biological testing technologies and products with applications throughout the diagnostics and life sciences industries. The company’s xMAP (Multi-Analyte Profiling) technology, an open architecture, multiplexing technology, allows simultaneous analysis of up to 500 bioassays from a small sample volume, typically a single drop of fluid, by reading biological tests on the surface of microscopic polystyrene beads called microspheres. xMAP technology combines this miniaturized liquid array bioassay capability with small lasers, light emitting diodes (LEDs), digital signal processors, photo detectors, charge-coupled device imaging and proprietary software to create a system. Products Instruments Luminex LX 100/200 (LX Systems): The LX Systems are compact analyzers that integrate fluidics, optics and digital signal processing to perform up to 100 bioassays simultaneously in a single tube or well of a microtiter plate using only a small amount of sample. By combining semiconductor lasers with digital signal processors and microcontrollers, these systems perform rapid, multi-analyte profiles under the control of a Windows-based personal computer and the company’s proprietary software. FLEXMAP 3D: The FLEXMAP 3D system is intended for use as a general laboratory instrument in markets, including life science research and diagnostics. This device can simultaneously measure up to 500 analytes from a single sample and offers increased speed and enhanced ease-of-use and serviceability. Like the company’s LX Systems, the FLEXMAP 3D system combines semiconductor lasers with digital signal processors and microcontrollers and these systems perform rapid, multi-analyte profiles under the control of a Windows-based personal computer and the company’s proprietary software. MAGPIX: The MAGPIX system is a multiplexing analyzer capable of performing qualitative and quantitative analysis of proteins and nucleic acids in various sample matrices. This system is Luminex’s newest instrument and can perform up to 50 tests in a single reaction volume, reducing sample input, reagents and labor while improving productivity. MAGPIX is based on a detection mechanism that uses LEDs and a charge-coupled device imaging system, rather than the lasers and detection mechanisms used in the company’s flow cytometry-based instruments. Consumables MicroPlex Microspheres: The company’s xMAP systems use polystyrene microspheres that are approximately 5.6 microns in diameter. The company dyes the microspheres in sets with varying intensities of a red and a near infrared dye to achieve approximately 100 distinct color sets. Each microsphere can carry the reagents of an enzymatic, genetic or immunologic bioassay. MagPlex Microspheres: These microspheres feature super-paramagnetic properties that make them ideal for running automated xMAP-based assays. The company dyes the microspheres in sets with varying intensities of a red and a near infrared dye to achieve up to 500 distinct color sets. These microspheres can be moved or held in place by a magnetic field. Many automated systems utilize magnetic properties to automate the performance of the assay. Automating sample testing using MagPlex microspheres on a robotic sample preparation system decreases hands-on technician time, improves precision, and streamlines workflow. xTAG Microspheres: These dyed microspheres are linked to a set of 100 proprietary nucleic acid capture sequences providing a universal array for DNA and RNA work. They are designed for conducting genotyping and other nucleic acid-based experiments in the life sciences markets. When used in conjunction with the company’s Luminex systems, the xTAG microspheres are designed to simplify the genotyping assay development process and increase assay flexibility. SeroMAP Microspheres: These 100 distinct sets of microspheres are designed for specific protein based serological applications. Certain Luminex partners use this product for enhanced sensitivity in serum-based assays. Calibration and Control Microspheres: Calibration microspheres a


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMNX:US $18.09 USD -0.43

LMNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Computer Programs & Systems Inc $57.31 USD +0.02
HealthStream Inc $19.79 USD -0.87
Meridian Bioscience Inc $18.74 USD +0.03
Quidel Corp $16.40 USD -0.49
Takara Bio Inc ¥1,102 JPY +70.00
View Industry Companies

Industry Analysis


Industry Average

Valuation LMNX Industry Range
Price/Earnings 20.9x
Price/Sales 3.2x
Price/Book 2.1x
Price/Cash Flow 19.1x
TEV/Sales 2.7x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LUMINEX CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at